Characterization of a New Biocomposite Based on Bioactive Compounds from Ganoderma lucidum and Jellyfish Collagen Destined for In Vitro Evaluation of Antitumor Effects in the Oral Cavity.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalPharmaceuticals (Basel, Switzerland)

Year2026

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Pharmaceuticals (Basel, Switzerland) in 2026. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Pascale C, Burcea A, Bogdan-Andreescu CF, Cadar E, Popescu A, Negreanu-Pirjol T, et al. (2026). Characterization of a New Biocomposite Based on Bioactive Compounds from Ganoderma lucidum and Jellyfish Collagen Destined for In Vitro Evaluation of Antitumor Effects in the Oral Cavity. Pharmaceuticals (Basel, Switzerland) https://doi.org/10.3390/ph19010108 PMID: 41599707

Open citation